Percutaneous sacroplasty for sacral metastatic tumors under fluoroscopic guidance only.
Percutaneous sacroplasty is a safe and effective procedure for sacral insufficient fractures under CT or fluoroscopic guidance; although, few reports exist about sacral metastatic tumors. We designed a pilot study to treat intractable pain caused by a sacral metastatic tumor with sacroplasty. A 62-year-old man and a 38-year-old woman with medically intractable pain due to metastatic tumors of S1 from lymphoma and lung cancer, respectively, underwent percutaneous sacroplasty. Over the course of the follow-up period, the two patients experienced substantial and immediate pain relief that persisted over a 3-month and beyond. The woman had deposition of PMMA (polymethyl methacrylate) in the needle track, but did not experience significant symptoms. No other peri-procedural complications were observed for either patient.
Zhang
Ji
J
Department of Radiology, Sixth Affiliated People's Hospital, Shanghai Jiao Tong University, No. 600, Yi Shan Road Shanghai, China.
Wu
Chun Gen
CG
Gu
Yi Feng
YF
Li
Ming Hua
MH
D000328:Adult; D001843:Bone Cements / Q000627:therapeutic use*; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D010148:Intractable Pain / Q000209:etiology / Q000628:therapy*; D019904:Polymethyl Methacrylate / Q000008:administration & dosage; D015641:Radiography, Interventional; D012447:Sacrum; D013125:Spinal Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000556:secondary*; D054854:Vertebroplasty / Q000379:methods
D001843:Bone Cements; D019904:Polymethyl Methacrylate